ANVISA Approves Regulatory Impact Analysis on Medical Cannabis

The Brazilian Health Regulatory Agency (ANVISA) recently approved a Regulatory Impact Analysis (RIA) report on medical cannabis. This development marks an important step towards the potential reshaping of cannabis regulations in Brazil, promising wide-ranging implications for public health, medical research, Read More …

Updated List of Brazilian Common Denominations

Brazil’s National Health Regulatory Agency (Agência Nacional de Vigilância Sanitária – Anvisa) has recently updated its list of Brazilian Common Denominations (Denominações Comuns Brasileiras – DCB), an essential step for the standardization and regulation of pharmaceutical substances in Brazil. The Read More …